BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$83.26−1.60 (-1.89%)
Close on Nov 18, 2026Market cap $20.92BP/E –Yield –
BioNTech shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 242M, up 0.5% from the year before. The highest annual figure on record is 260M in fiscal 2021.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 242M | +0.5% |
| FY2024 | Dec 31, 2024 | 240M | -0.9% |
| FY2023 | Dec 31, 2023 | 243M | -2.8% |
| FY2022 | Dec 31, 2022 | 250M | -3.8% |
| FY2021 | Dec 31, 2021 | 260M | +4.5% |
| FY2020 | Dec 31, 2020 | 249M | +17.5% |
| FY2019 | Dec 31, 2019 | 212M | +10.9% |
| FY2018 | Dec 31, 2018 | 191M | +14.4% |
| FY2017 | Dec 31, 2017 | 167M | – |
See a number that looks wrong?